Goldberg-Cohen et al: Regulation of vascular endothelial growth factor by hypoxiaChen CY, Chen TM, Shyu AB (1994) Interplay of twofunctionally and structurally distinct domains of the c-fosAU-rich element specifies its mRNA-destabilizing function.Mol Cell Biol 14, 416-426.Claffey KP, Shih SC, Mullen A, Dziennis S, Cusick JL, AbramsKR, et al (1998) Identification of a human VPF/VEGF 3'untranslated region mediating hypoxia-induced mRNAstability. Mol Biol Cell 9, 469-481.Damert A, Machein M, Breier G, Fujita MQ, Hanahan D, RisauW, et al (1997) Up-regulation of vascular endothelial growthfactor expression in a rat glioma is conferred by two distincthypoxia-driven mechanisms. Cancer Res 57, 3860-3864.De Vries C, Escobedo JA, Ueno H, Houck K, Ferrara N,Williams LT (1992) The fms-like tyrosine kinase, a receptorfor vascular endothelial growth factor. Science 255, 989-991.Deroanne CF, Hajitou A, Calberg-Bacq CM, Nusgens BV,Lapiere CM (1997) Angiogenesis by fibroblast growth factor4 is mediated through an autocrine up-regulation of vascularendothelial growth factor expression. Cancer Res 57, 5590-5597.Fan XC, Steitz JA (1998) HNS, a nuclear-cytoplasmic shuttlingsequence in HuR. Proc Natl Acad Sci U.S.A 95, 15293-15298.Ferrara N (1999) Role of vascular endothelial growth factor inthe regulation of angiogenesis. Kidney Int 56, 794-814.Ferrara N, Henzel WJ (1989) Pituitary follicular cells secrete anovel heparin-binding growth factor specific for vascularendothelial cells. Biochem Biophys Res Commun 161, 851-858.Finkenzeller G, Sparacio A, Technau A, Marme D, Siemeister G(1997) Sp1 recognition sites in the proximal promoter of thehuman vascular endothelial growth factor gene are essentialfor platelet-derived growth factor-induced gene expression.Oncogene 15, 669-676.Frank S, Hubner G, Breier G, Longaker MT, Greenhalgh DG,Werner S (1995) Regulation of vascular endothelial growthfactor expression in cultured keratinocytes. Implications fornormal and impaired wound healing. J Biol Chem 270,12607-12613.Gerber HP, Kowalski J, Sherman D, Eberhard DA, Ferrara N.(2000) Complete inhibition of rhabdomyosarcoma xenograftgrowth and neovascularization requires blockade of bothtumor and host vascular endothelial growth factor. CancerRes. 60, 6253-6258.Goldberg-Cohen I, Furneauxb H, Levy AP (2002) A 40-bp RNAelement that mediates stabilization of vascular endothelialgrowth factor mRNA by HuR. J Biol Chem 277, 13635-13640.Houck KA, Ferrara N, Winer J, Cachianes G, LI B, Leung DW(1991) The vascular endothelial growth factor family:identification of a fourth molecular species andcharacterization of alternative splicing of RNA. MolEndocrinol 5, 1806-1814.Iliopoulos O, Levy AP, Jiang C, Kaelin WGJ, Goldberg MA(1996) Negative regulation of hypoxia-inducible genes bythe von Hippel-Lindau protein. Proc Natl Acad Sci U.S.A93, 10595-10599.Jain RG, Andrews LG, Mcgowan KM, Pekala PH, Keene JD(1997) Ectopic expression of Hel-N1, an RNA-bindingprotein, increases glucose transporter (GLUT1) expression in3T3-L1 adipocytes. Mol Cell Biol 17, 954-962.Kenan DJ, Query CC, Keene JD (1991) RNA recognition:towards identifying determinants of specificity. TrendsBiochem Sci 16, 214-220.Kim KJ, Li B, Winer J, Armanini M, Gillett N, Phillips HS, et al(1993) Inhibition of vascular endothelial growth factorinducedangiogenesis suppresses tumour growth in vivo.Nature 362, 841-844.Kim SH, Suddath FL, Quigley GJ, Mcpherson A, Sussman JL,Wang AH, et al (1974) Three-dimensional tertiary structureof yeast phenylalanine transfer RNA. Science 185, 435-440.King PH, Levine TD, Fremeau RTJ, Keene JD (1994)Mammalian homologs of Drosophila ELAV localized to aneuronal subset can bind in vitro to the 3' UTR of mRNAencoding the Id transcriptional repressor. J Neurosci 14,1943-1952.Lai WS, Blackshear PJ. (2001) Interactions of CCCH zinc fingerproteins with mRNA: tristetraprolin-mediated AU-richelement-dependent mRNA degradation can occur in theabsence of a poly(A) tail. J Biol Chem 276, 23144-23154.Lee CG, Heijn M, Di Tomaso E, Griffon-Etienne G,Ancukiewicz M, Koike C, et al (2000) Anti-Vascularendothelial growth factor treatment augments tumor radiationresponse under normoxic or hypoxic conditions. Cancer Res60, 5565-5570.Levy NS, Chung S, Furneaux H, Levy AP (1998) Hypoxicstabilization of vascular endothelial growth factor mRNA bythe RNA-binding protein HuR. J Biol Chem 273, 6417-6423.Ma WJ, Cheng S, Campbell C, Wright A, Furneaux H (1996)Cloning and characterization of HuR, a ubiquitouslyexpressed Elav-like protein. J Biol Chem 271, 8144-8151.Ma WJ, Chung S, Furneaux H (1997) The Elav-like proteins bindto AU-rich elements and to the poly(A) tail of mRNA.Nucleic Acids Res 25, 3564-3569.Maher ER, Kaelin WGJ (1997) von Hippel-Lindau disease.Medicine 76, 381-391.Mukhopadhyay D, Knebelmann B, Cohen HT, Ananth S,Sukhatme VP (1997) The von Hippel-Lindau tumorsuppressor gene product interacts with Sp1 to repressvascular endothelial growth factor promoter activity. MolCell Biol 17, 5629-5639.Pertovaara L, Kaipainen A, Mustonen T, Orpana A, Ferrara N,Saksela O, et al (1994) Vascular endothelial growth factor isinduced in response to transforming growth factor-beta infibroblastic and epithelial cells. J Biol Chem 269, 6271-6274.Plouet J, Schilling J, Gospodarowicz D (1989) Isolation andcharacterization of a newly identified endothelial cellmitogen produced by AtT-20 cells. EMBO J 8, 3801-3806.Risau W (1997) Mechanisms of angiogenesis. Nature 386, 671-674.Robinow S, Campos AR, YAO KM, White K (1988) The elavgene product of Drosophila, required in neurons, has threeRNP consensus motifs. Science 242, 1570-1572.Robinow S, White K (1991) Characterization and spatialdistribution of the ELAV protein during Drosophilamelanogaster development. J Neurobiol 22, 443-461.Ryuto M, Ono M, Izumi H, Yoshida S, Weich HA, Kohno K, etal (1996) Induction of vascular endothelial growth factor bytumor necrosis factor alpha in human glioma cells. Possibleroles of SP-1. J Biol Chem 271, 28220-28228.Semenza GL, Jiang BH, Leung SW, Passantino R, Concordet JP,Maire P, et al (1996) Hypoxia response elements in thealdolase A, enolase 1, and lactate dehydrogenase A genepromoters contain essential binding sites for hypoxiainduciblefactor 1. J Biol Chem 271, 32529-32537.72
<strong>Gene</strong> <strong>Therapy</strong> and <strong>Molecular</strong> <strong>Biology</strong> Vol 7, page 73Shaw G, Kamen R (1986) A conserved AU sequence from the 3'untranslated region of GM-CSF mRNA mediates selectivemRNA degradation. Cell 46, 659-667.Shibuya M, Yamaguchi S, Yamane A, Ikeda T, Tojo A,Matsushime H, et al (1990) Nucleotide sequence andexpression of a novel human receptor-type tyrosine kinasegene (flt) closely related to the fms family. Oncogene 5, 519-524.Soker S, Fidder H, Neufeld G, Klagsbrun M (1996)Characterization of novel vascular endothelial growth factor(VEGF) receptors on tumor cells that bind VEGF165 via itsexon 7-encoded domain. J Biol Chem 271, 5761-5767.Stein I, Itin A, EinaT P, Skaliter R, Grossman Z, Keshet E (1998)Translation of vascular endothelial growth factor mRNA byinternal ribosome entry: implications for translation underhypoxia. Mol Cell Biol 18, 3112-3119.Stein I, Neeman M, Shweiki D, Itin A, Keshet E (1995)Stabilization of vascular endothelial growth factor mRNA byhypoxia and hypoglycemia and coregulation with otherischemia-induced genes. Mol Cell Biol 15, 5363-5368.Szabo A, Dalmau J, Manley G, Rosenfeld M, Wong E, Henson J,et al (1991) HuD, a paraneoplastic encephalomyelitisantigen, contains RNA-binding domains and is homologousto Elav and Sex-lethal. Cell 67, 325-333.Terman BI, Carrion ME, Kovacs E, Rasmussen BA, Eddy RL,Shows TB (1991) Identification of a new endothelial cellgrowth factor receptor tyrosine kinase. Oncogene 6, 1677-1683.Terman BI, Dougher-Vermazen M, Carrion ME, Dimitrov D,Armellino DC, Gospodarowicz D, et al (1992) Identificationof the KDR tyrosine kinase as a receptor for vascularendothelial cell growth factor. Biochem Biophys ResCommun 187, 1579-1586.Vincenti V, Cassano C, Rocchi M, Persico G (1996) Assignmentof the vascular endothelial growth factor gene to humanchromosome 6p21.3. Circulation 93, 1493-1495.Waltenberger J, Claesson-Welsh L, Siegbahn A, Shibuya M,Heldin CH (1994) Different signal transduction properties ofKDR and Flt1, two receptors for vascular endothelial growthfactor. J Biol Chem 269, 26988-26995.Wang GL, Semenza GL (1995) Purification and characterizationof hypoxia-inducible factor 1. J Biol Chem 270, 1230-1237.Yoshida A, Anand-Apte B, Zetter BR (1996) Differentialendothelial migration and proliferation to basic fibroblastgrowth factor and vascular endothelial growth factor.Growth Factors 13, 57-64.73
Change language